Seasonal and monthly variation in multiple sclerosis relapses: a systematic review and meta-analysis

Abstract

Background Multiple Sclerosis (MS) relapses are episodes of transient disease exacerbation. There are contradictory findings regarding seasonal variation in MS relapses. In this systematic review and meta-analysis, we aimed to investigate the seasonal and monthly variation in relapse rates among patients with MS. Methods We systematically queried PubMed, Scopus, and Web of Science for published papers until February 30, 2022. Results A total of 24 studies were included in this systematic review and meta-analysis with a total of 29,106 patients with MS. We found that the relapse rate was significantly lower in fall compared to the average relapse rate in other seasons with a risk ratio (RR) of 0.97 (95 CI 0.95-0.98). Furthermore, patients with MS experienced a higher number of relapses in April (RR: 1.06, 95 CI 1.01-1.11) and March (RR: 1.08, 95 CI 1.00-1.16) compared to other months. Also, the risk of relapse was lower in August (RR: 0.92, 95 CI.85-0.98), September (RR: 0.97, 95 CI.94-0.99), October (RR: 0.92, 95 CI.89-0.96), and November (RR: 0.93, 95 CI.89-0.97). Conclusion Our systematic review and meta-analysis confirm the temporal fluctuations in the relapse of MS through a comprehensive review of the existing literature, with a lower relapse rate during late summer and fall and a higher relapse rate during early spring.